International Therapeutics (United States)
- Research works
- 25 ▲ 148% vs 2013–17
- Citations
- 1.2k 48.6 per fractional work
- Top-10% rate
- 7.9% record average 16.5%
- Open access
- 24% world 28%
Not ranked overall: International Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 6.7×. Every wedge is a field page.
Which keywords describe research at International Therapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Tumor Microenvironment, Antiretroviral Therapy, Epidemiology, Extracellular Matrix, Cancer Immunotherapy, Immune Response, Immunotherapy and Chronic Kidney Disease.
- PD-1 and PD-L1
- Chronic Kidney Disease
- CAR T Cells
- Immune Response
- Cancer
- Antiretroviral Therapy
- Inflammation
- Epidemiology
- Tumor Microenvironment
- Extracellular Matrix
- Cancer Immunotherapy
- Immunotherapy
- Chimeric Antigen Receptor
- Immune Checkpoint Blockade
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Epidemiology2▲ 2.4×13 topics
- Inflammation2▲ 2.8×11 topics
- Tumor Microenvironment2▲ 19×4 topics
- Antiretroviral Therapy1▲ 23×3 topics
- Extracellular Matrix1▲ 22×3 topics
- Cancer1▲ 3.5×6 topics
- Cancer Immunotherapy1▲ 32×2 topics
- Immune Response1▲ 7.1×6 topics
- Immunotherapy1▲ 6.9×4 topics
- CAR T Cells1▲ 94×1 topic
- Chimeric Antigen Receptor1▲ 94×1 topic
- Chronic Kidney Disease1▲ 17×5 topics
- Immune Checkpoint Blockade1▲ 74×1 topic
- PD-1 and PD-L11▲ 74×1 topic
Which research topics does International Therapeutics (United States) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Medical Imaging Techniques and Applications and Cancer, Hypoxia, and Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 5 Cancer Treatment and Pharmacology Oncology 0 works
- 6 Long-Term Effects of COVID-19 Neurology 0 works
- 7 Statistical Methods in Clinical Trials Statistics and Probability 0 works
- 8 Cardiac Ischemia and Reperfusion Pathology and Forensic Medicine 0 works
- 9 Heart rate and cardiovascular health Cardiology and Cardiovascular Medicine 0 works
- 10 COVID-19 Clinical Research Studies Infectious Diseases 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has International Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 148% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seattle
- University of Washington
- Seattle University
- Fred Hutch Cancer Center
- University of Washington Medical Center
- University of Washington Applied Physics Laboratory
- Seattle Children's Hospital
- Amazon (United States)
- Virginia Mason Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.